KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Non Operating Investment Income: 2017

Historic Non Operating Investment Income for Aurinia Pharmaceuticals (AUPH) over the last 1 years, with Dec 2017 value amounting to -$78,000.

  • Aurinia Pharmaceuticals' Non Operating Investment Income was N/A to $124,000 in Q3 2020 from the same period last year, while for Sep 2020 it was $128,000, marking a year-over-year change of. This contributed to the annual value of -$78,000 for FY2017, which is N/A change from last year.
  • Latest data reveals that Aurinia Pharmaceuticals reported Non Operating Investment Income of -$78,000 as of FY2017.
  • Over the past 5 years, Aurinia Pharmaceuticals' Non Operating Investment Income peaked at -$78,000 during FY2017, and registered a low of -$78,000 during FY2017.
  • Over the past 1 years, Aurinia Pharmaceuticals' median Non Operating Investment Income value was -$78,000 (recorded in 2017), while the average stood at -$78,000.